I meant wrong assumption about my risk appetite.
I think the valuation won't come in as high as many expect due to lower qty and slow ramp up time.
Obviously it's up to shareholders to vote or not. However, I'm not sure they will be happy with the valuation as I presume it will be on a lower Mtpa, resulting in a lower NPV and not the value many think its worth.
20c+ price target. So $300m Market cap with the expected dilution?
What Mtpa/NPV are you basing that on?
Does anyone know what volume the studies are targeting?
I've spent a lot of time looking through the project and am genuinely interested in it, but right now I cant value it with so many unknowns.
I meant wrong assumption about my risk appetite. I think the...
Add to My Watchlist
What is My Watchlist?
